-
"What factors influence health plan coverage of drugs for rare diseases?"
#ISPORAnnual Panel moderated by my PI Dr. James Chambrrs@TuftsCEVR#ISPOR2019 pic.twitter.com/xCyRisrrAc
Prikaži ovu nit -
ASK THE PATIENT, a plea by Fleur Chandler from
#DuchenneUK at the exciting first plenary on the dawn of disruption in healthcare at#ISPOR2019 -
There’s no camera capable of capturing the thousands of people attending the 2nd plenary at
#ISPOR2019 in#Copenhagen!@ernestoiadanza@AmyPavlock@SWerkoe@AdrianaVelBer@MedicalDevicesG@decide_healthpic.twitter.com/9aBNCLG0BN
Prikaži ovu nit -
#ISPOR2019.@NHCouncil's Eleanor Perfetto: We've gotten so much better at asking patients questions about value but we're using legacy tools.pic.twitter.com/E2Lq7Dr6ZS
-
Good to hear
@CaulfieldTim focus on population health and evidence at#ISPOR2019 - need to balance the fascination with proprietary technologies with an understanding of the determinants of health and the value of population-level interventions. -
Long-term prevalence of antidepressant drugs at
#ISPOR2019 pic.twitter.com/fhxiy5qDiM
-
Come and see us to boost your career in drug safety
and #health economy
at #Eu2P booth 802#ISPORAnnual#ISPOR2019 pic.twitter.com/S2CXE8n3dw
-
If you are at
#ISPOR2019 be sure to chat with @Dr_Sean_Murphy about his poster on the determinants of an efficient model of extended-release naltrexone initiation for the treatment of#opioid use disorder! Be sure to ask about the consultation service he directs as well!pic.twitter.com/Veulm73rZU
-
A great discussion about “TO REGISTER OR NOT REGISTER (THE PROTOCOL). THAT IS THE QUESTION IN OBSERVATIONAL AND BIG DATA STUDIES, ECONOMIC MODELS, AND COST-EFFECTIVENESS ANALYSIS “
#ispor#ispor2019#cevr#rwe#clinicaltrial#science#ethics#healthpolicy@TuftsCEVRpic.twitter.com/arNnZLV9MK
-
@jchambers241 currently leading a compelling discussion on how to pay for orphan drugs at#ISPOR2019 pic.twitter.com/vZEhea4C4M
-
Come see our poster on the new QALY measure for use in mental health - REQOL-UI.
#ispor2019 pic.twitter.com/cvyXKZLkPy
-
On our way from YYZ to
#ispor2019 and Salman, our gate agent@Delta is handling frazzled travelers like a pro, with kindness, patience and great communication. Thanks for getting us on our way with a smile! -
At
#ISPOR2019 in New Orleans, hearing from some of my professional heros, studying how to increase value in health. Shout out to@PeterNeumann11 for bringing the field to Twitter
pic.twitter.com/flC4SlZe3g
-
Meet Micah Rose, Technical Adviser from our team
@ISPORorg who will be presenting his poster tomorrow#ISPOR2019 pic.twitter.com/MrWKKaTfN2
-
“We need to figure out out when it works and when it doesn’t. We don’t know yet until we see a lot more groups trying and failing, trying and succeeding”
@DrBlytheAdamson@InfectiousEcon#ispor2019#isporannual@flatironhealthpic.twitter.com/dgCPxwNdoj
-
ANYWAY I forgot to tweet the good news that I got an abstract accepted into
#ispor2019 for a poster session. I am now a real phd student! -
It's an absolute pleasure to be a new member of Ed Board - keep up the good work! In few discussions at
#ispor2019 i have had, the good reviewer process of@ApplHealthEcon has come up! And whether Editors should have a full time job as Editors, which i think is a great idea! -
My first HEOR conference at
#ISPOR2019 is coming to the end. Excellent short courses and sessions, fun attendees and conversations. Looking forward to coming back next year. -
Fantastic talk on biosimilars and patent law challenges by Ha Kung Wong
#ISPORAnnual#ISPOR2019@ISPORorgpic.twitter.com/akThkjgauw
-
Full house? Bursting at the seams, rather!!!
#ispor2019 an outstanding success https://twitter.com/IFMBE_HTAD/status/1191628234875686913 …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.